ImmunityBio, Inc. IBRX Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s accumulated depreciation?
- ImmunityBio, Inc. (IBRX) reported accumulated depreciation of $115.75M in Q1 2026.
- How has ImmunityBio, Inc.'s accumulated depreciation changed year-over-year?
- ImmunityBio, Inc.'s accumulated depreciation increased by 12.4% year-over-year, from $102.94M to $115.75M.
- What is the long-term trend for ImmunityBio, Inc.'s accumulated depreciation?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s accumulated depreciation has grown at a 21.9% compound annual growth rate (CAGR), from $41.86M to $112.49M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.